Literature DB >> 16186176

Hyperfibrinogenemia is a useful predictor for lymphatic metastasis in human gastric cancer.

Hiroharu Yamashita1, Joji Kitayama, Hirokazu Nagawa.   

Abstract

BACKGROUND: Although abnormal hemostasis has been described in cancer patients, the precise association between the plasma fibrinogen level and lymphatic metastasis has not been reported in a large-scale clinical study.
METHODS: Preoperative plasma levels of fibrinogen as well as C-reactive protein (CRP) and carcinoembryonic antigen (CEA) were retrospectively examined in 649 patients who underwent surgery for gastric cancer, and the correlation between these factors and nodal status was evaluated.
RESULTS: Plasma fibrinogen level in patients with gastric cancer showed a positive association with nodal classification (P < 0.0001). Hyperfibrinogenemia (>310 mg/dl) as well as high CEA (>5 ng/ml) and CRP (>0.3 mg/dl) showed a significant association with nodal metastasis in univariate analysis. Multivariate analysis revealed that hyperfibrinogenemia had an independent association with nodal metastasis (odds ratio, 2.004 (1.140-3.521); P = 0.0157), whereas CEA and CRP were not independent factors. Hyperfibrinogenemia showed an independent association even in advanced cancer [odds ratio 2.611 (1.404-4.854), P = 0.0024, n = 319]. When the 649 gastric cancers were classified into intestinal-type and gastric-type adenocarcinomas, plasma fibrinogen level was correlated with nodal metastasis only in the intestinal-type.
CONCLUSIONS: Our results suggest that hyperfibrinogenemia may provide favorable circumstances for cancer cells to metastasize via the lymphatic system. Preoperative plasma fibrinogen level is a useful predictor of lymphatic metastasis in intestinal-type gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16186176     DOI: 10.1093/jjco/hyi150

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  30 in total

1.  High preoperative plasma fibrinogen is an independent predictor of distant metastasis and poor prognosis in renal cell carcinoma.

Authors:  Jun Du; Jian-Hua Zheng; Xu-Sheng Chen; Qing Yang; Yan-Hui Zhang; Lei Zhou; Xin Yao
Journal:  Int J Clin Oncol       Date:  2012-05-19       Impact factor: 3.402

2.  Hyperfibrinogenemia is associated with inflammatory mediators and poor prognosis in patients with gastric cancer.

Authors:  Takashi Suzuki; Hideaki Shimada; Tatsuki Nanami; Yoko Oshima; Satoshi Yajima; Masaaki Ito; Naohiro Washizawa; Hironori Kaneko
Journal:  Surg Today       Date:  2016-05-09       Impact factor: 2.549

3.  Serum interleukin-6 and -10 levels in patients with gastric cancer.

Authors:  Masahide Ikeguchi; Tomoko Hatada; Manabu Yamamoto; Takanori Miyake; Tomonori Matsunaga; Youji Fukumoto; Yoshinori Yamada; Kenji Fukuda; Hiroaki Saito; Shigeru Tatebe
Journal:  Gastric Cancer       Date:  2009-06-27       Impact factor: 7.370

4.  Prognostic significance of hyperfibrinogenemia in patients with esophageal squamous cell carcinoma.

Authors:  Takashi Suzuki; Hideaki Shimada; Tatsuki Nanami; Yoko Oshima; Satoshi Yajima; Naohiro Washizawa; Hironori Kaneko
Journal:  Int J Clin Oncol       Date:  2017-01-07       Impact factor: 3.402

5.  Value of fibrinogen and D-dimer in predicting recurrence and metastasis after radical surgery for non-small cell lung cancer.

Authors:  He-Guo Jiang; Jian Li; Shun-Bing Shi; Ping Chen; Li-Ping Ge; Qian Jiang; Xin-Ping Tang
Journal:  Med Oncol       Date:  2014-05-27       Impact factor: 3.064

6.  Usefulness of Preoperative Plasma Fibrinogen Versus Other Prognostic Markers for Predicting Gastric Cancer Recurrence.

Authors:  Masaaki Yamamoto; Yukinori Kurokawa; Yasuhiro Miyazaki; Tomoki Makino; Tsuyoshi Takahashi; Makoto Yamasaki; Kiyokazu Nakajima; Shuji Takiguchi; Masaki Mori; Yuichiro Doki
Journal:  World J Surg       Date:  2016-08       Impact factor: 3.352

7.  The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial.

Authors:  V Seebacher; S Polterauer; C Grimm; H Husslein; H Leipold; K Hefler-Frischmuth; C Tempfer; A Reinthaller; L Hefler
Journal:  Br J Cancer       Date:  2010-02-16       Impact factor: 7.640

8.  Effect of preoperative hyperfibrinogenemia on recurrence of colorectal cancer without a systemic inflammatory response.

Authors:  Hiroharu Yamashita; Joji Kitayama; Masataka Taguri; Hirokazu Nagawa
Journal:  World J Surg       Date:  2009-06       Impact factor: 3.352

9.  Thrombocytosis before pre-operative chemoradiotherapy predicts poor response and shorter local recurrence-free survival in rectal cancer.

Authors:  Kazushige Kawai; Joji Kitayama; Nelson H Tsuno; Eiji Sunami; Toshiaki Watanabe
Journal:  Int J Colorectal Dis       Date:  2012-10-19       Impact factor: 2.571

10.  Multimodal preoperative evaluation system in surgical decision making for rectal cancer: a randomized controlled trial.

Authors:  Xiaodong Wang; Donghao Lv; Huan Song; Lei Deng; Qiang Gao; Junhua Wu; Yingyu Shi; Li Li
Journal:  Int J Colorectal Dis       Date:  2010-03       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.